EVCM vs AAPG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
EVCM · EverCommerce$8.22 ▼ 1.56%
AAPG · Ascentage Pharma$15.43 ▲ 1.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- EVCM -7.0%
- AAPG -52.4%
Head to head
| Metric | EVCM | AAPG |
|---|---|---|
| Price | $8.22 | $15.43 |
| Change today | ▼ 1.56% | ▲ 1.98% |
| Market cap | $1.44B | $1.44B |
| Return, 3 months | -19.6% | -18.2% |
| Return, year to date | -32.1% | -41.2% |
| Return, 1 year | -12.1% | -51.4% |
| P/E (TTM) | 48.4 | -6.5 |
| P/B | 2.0 | 17.3 |
| P/E percentile vs own 5y | 82nd | 99th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +2.7% | -41.5% |
| Net profit growth (YoY) | +19.2% | -206.4% |
| Gross margin | 77.8% | 93.9% |
| Operating margin | 9.9% | -216.7% |
| Net margin | 5.7% | -228.5% |
| Return on equity | 4.7% | -240.3% |
| Analyst target vs. price | +33.8% | +172.2% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 38 | 52 |
| 30-day volatility | 64.8% | 72.0% |
| Max drawdown, 1 year | -52.9% | -61.0% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- EVCM is the largest of the group by market value.
- EVCM has returned the most over the past year.
- AAPG carries the lowest trailing P/E.
- EVCM is growing revenue fastest.
- EVCM keeps the most profit per dollar of sales.
- EVCM has been the calmest stock over the last 30 days.